facebook button LocoMMotion: Multiple Myeloma Registry
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

LocoMMotion: Multiple Myeloma Registry

Sponsor: Janssen Scientific and Medical Affairs

Protocol 68284528MMY4001. A Prospective, Multinational Study of Real-Life Current Standards of Care in Patients with Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including PI, IMiD, and CD38 Monoclonal Antibody Treatment